Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110604
Status:
COMPLETED
Last Update Posted:
2008-12-31
First Post:
2005-05-10
Brief Title:
The Effect of Folic Acid on Atherosclerosis Cognitive Performance and Hearing
Sponsor:
Wageningen University
Organization:
Wageningen University
Study Overview
Official Title:
The Folic Acid and Carotid Intima-Media Thickness FACIT Study A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2005-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if folic acid supplementation can slow down atherosclerotic progression age-related cognitive decline and age-related hearing loss
Detailed Description:
Low levels of B vitamins in particular folate and high levels of plasma total homocysteine have been associated with a variety of age-related diseases and disorders including cardiovascular disease dementia and hearing impairment Extra folate for example in the form of folic acid is known to decrease the concentrations of plasma total homocysteine
We examined whether 08 mgd folic acid could slow down atherosclerotic progression and the above mentioned age-related processes
We examined whether 08 mgd folic acid could slow down atherosclerotic progression and the above mentioned age-related processes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ZonMw 20010002 | None | None | None |